You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Integrated Computational Material Engineering Approach to Additive Manufacturing for Stainless Steel (316L)
SBC: SENVOL LLC Topic: N16AT022The objective in this project is to implement and validate a probabilistic qualification framework that will enable additive manufacturing (AM) materials and part qualification through the use of a data-driven predictive model within a statistical framework. Senvol seeks to develop and validate a data-driven ICME probabilistic framework for assisting qualification of AM materials and parts. Phase ...
STTR Phase II 2018 Department of DefenseNavy -
Validation of a salivary miRNA diagnostic test for autism spectrum disorder
SBC: Quadrant Biosciences Inc. Topic: 103Autism spectrum disorder (ASD) is a continuum of neurodevelopmental characteristics that includes deficits in communication and social interaction, as well as restrictive, repetitive interests and behaviors. ASD is an increasing public health concern, with about 1 in 45 American children diagnosed with ASD in 2014, a 10-fold increase in prevalence over the past 40 years. The effect of ASD on both ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Active Control of a Scramjet Engine
SBC: Innoveering, LLC Topic: AF15AT19In this effort, Innoveering will integrate and test a closed-loop active control system for scramjet isolator shock system positioning. The approach is to control the fuel flow to the engine to position the shock train leading edge at a specified location in the isolator. The control system includes three basic elements: a shock position sensing system based, a fast response fuel valve that adjust ...
STTR Phase II 2016 Department of DefenseAir Force -
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
SBC: LEUKOGENE THERAPEUTICS INC Topic: 102Project Summary Abstract Multiple MyelomaMMis the second most common form of blood cancer and remains an incurable and deadly diseaseProteasome inhibitorPItherapy is a cornerstone in the treatment of MMbut resistance to this class of agent is an emerging challenge in the clinicNew therapeutic approaches that specifically target resistance are needed to maximize responses and ultimately produce cur ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Novel SCD1 inhibitors for treatment of cancer
SBC: MODULATION THERAPEUTICS, INC. Topic: 102Project Summary Metabolic reprogramming plays a critical role in carcinogenesisin part due its ability to promote immune suppressive properties within tumorsHoweverit is unclear whether inhibition of fatty acid metabolism in tumors affects their immunogenicityHerewe show for the first time that inhibition of stearoyl CoA desaturaseSCDthe rate limiting enzyme involved in fatty acid synthesis conver ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Energy Efficient, Non-Silicon Digital Signal Processing (DSP)
SBC: HYPRES INC Topic: N17AT027Superconductor digital circuits, operating at very high clock speed, can directly process wideband digitized radio frequency (RF) signals. By integrating such digital processing circuitry together with superconductor analog-to-digital converters (ADCs), we propose to develop the next generation digital-RF receivers. Leveraging the recent development of multiple superconductor ADCs on the same chip ...
STTR Phase II 2018 Department of DefenseNavy -
Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S): Cyber Superiority for Air Force Combatant Commanders Using Cyber-domain
SBC: ANDRO COMPUTATIONAL SOLUTIONS LLC Topic: AF08BT06ABSTRACT: In this effort selected SBIR technologies will be matured and merged to establish the Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S) for enhancing the throughput, spectral efficiency, speed, reliability and security performance of software defined radio (SDR) communication networks. One of the core technologies in the AC4S architecture is the Cyber Superior ...
STTR Phase II 2016 Department of DefenseAir Force -
Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S): Dynamic Cross-layer Routing Using Cognitive Spectrum Allocation (AXL-RO
SBC: ANDRO COMPUTATIONAL SOLUTIONS LLC Topic: AF10BT09ABSTRACT: In this effort selected SBIR technologies will be matured and merged to establish the Adaptive Cyber-secure Cross-layer Communications-Classification System (AC4S) for enhancing the throughput, spectral efficiency, speed, reliability and security performance of software defined radio (SDR) communication networks. One of the core technologies that forms the basis of AC4S is the AXL-ROSA s ...
STTR Phase II 2016 Department of DefenseAir Force -
Development and validation of therapy for mucopolysaccharidosis III
SBC: Phoenix Nest Inc. Topic: 105DESCRIPTION provided by applicant Sanfilippo syndrome mucopolysaccharidosis type III MPS III is a devastating neurodegenerative lysosomal storage disorder of childhood for which there is presently no cure or effective treatment available The fundamental cause of MPS III is an inherited mutation in one of the enzymes required to catabolize heparan sulfate HS a glycosaminoglycan which pla ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Electronic Optimization of Stem Cell Derived Human Cardiac Myocytes
SBC: Cytocybernetics Inc Topic: NHLBIProject Summary As part of the FDA approval process for novel therapeutic drugssafety screening demonstrating that the candidate drug does not have deleterious effects on the human cardiac action potential is requiredHealthy human heart cells are not available for such preclinical drug testingThere is currently no consensus on the best experimental approach to provide the most efficienteconomicala ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health